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Diarrhoeal diseases are still the major paediatric health
concern worldwide which contributes to 2.5 million
annual deaths in children.1 The therapy of using Oral
Rehydration Solution (ORS) and nutritional manage-
ment are considered to be the best choice for the
management of diarrhoea in young children.2 The ORS
reduces the risk of mortality by averting the dehydration
but it does not help in reducing the frequency and
consistency of stools.3
Zinc supplementation along with ORS has emerged as
a potent approach to treat diarrhoea and studies have
endorsed the fact that use of Zinc is associated with a
significant reduction in duration of diarrhoea.4,5 The
World Health Organization (WHO) also recommended
daily Zinc supplements for 10-14 days for children with
acute diarrhoea. However, there are still some enduring
gaps in the information about dose and intake of Zinc
supplementation, it is not clear what form of Zinc is more
acceptable and effective. 
A longitudinal cohort study was conducted among children
to measure the impact of daily Zinc administration in
different formulations. There were two groups in the
study; one group received Zinc in the form of suspension
whereas the other group received Zinc in the form of
dispersible tablets. Zinc was given in a dose of 3 RDA
(1 RDA = 5 mg per day for infant and 10 mg per day
for children) as per standard recommendations. The
standard WHO treatment for the management of acute
diarrhoea was also provided to the enrolled cases. 
A sample size of 200 patients was calculated assuming
80% Power, 95% CI and 20% Improved recovery rates,
by using the approximate sample size formula. The
enrolled children were brought to the hospital with acute
gastroenteritis both from inpatient and outpatient units.
Diarrhoea was defined as the passage of 3 or more
loose or watery stools in the 24-hour period before
enrolment. Eligible children were screened by a
physician and recruited in the study, after the screening
a verbal consent was obtained from the parents or
caretaker and the patient was randomized in one of the
two groups. Children were randomized either of the 2
intervention using block randomization. 
Patients were examined and daily information on
morbidity and general health at the time of recruitment
and on follow-up days 1, 2 and 3 was recorded. Follow-
ups were done only for 3 days due to limited resources,
short stay of patients at Camp Hospital and reluctance
of patient to come back for follow-up. Data was collected
on illness characteristics, frequency of stools and
vomiting, hydration status and the use of the supplement
per day since the last visit was noted. Compliance was
measured by reported intake and by measuring the
remaining volume of syrup in the returned bottles and
tablets in the strips respectively. 
Data was entered in Visual FoxPro version 7 and statistical
analysis was conducted using SPSS 14 (SPSS Inc.
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Chicago, IL, USA). Mean and standard deviation were
calculated for continuous variables and frequency and
percentages were computed for categorical variables.
Chi-square test was used to see association among
categorical variables.
The baseline characteristics of the patients in both
groups were similar. All the cases were recruited in the
study and randomized in one of the two groups to
receive the Zinc formulation along with the conventional
treatment of diarrhoea. It was intended to treat all the
cases with Zinc suspension but 15% of cases were
dropped out during the study and could not receive the
Zinc formulations. Those cases were excluded from
analysis because the compliance of Zinc could not be
analysed on them. So the effectiveness of Zinc
formulations were analysed among 190 cases, 81 and
109 respectively in group A and B. The main reasons for
the drop outs were cultural beliefs, left against medical
advice, referrals and refusal for the treatment.
The mean of total frequency of stool during the last 24
hours were 12, almost equal in both groups and the
frequency of stools after starting supplementation were
7.2 ± 4.4 and 6.0 ± 3.8 on day 1, 4.2 ± 3.4 and 2.6 ± 2.4
on day 2, and 2.4 ± 1.6 and 1.6 ± 1.1 on day 3 in group
A and B respectively. Significant p-values were
established among Zinc use and reduction in frequency
of stools on Day 2 and Day 3, with comparatively better
outcome in group B. Furthermore about 90% of the
patients recovered from diarrhoea within 3 days of
presentation, 82% from group A and 96% from group B.
On comparison of group A and B the recovery rates for
group B was found to be significantly higher up to 4.76
(1.63 - 13.90) with p-values of 0.001 (Table I). Therefore,
a considerable effect of Zinc on duration and frequency
of diarrhoea was found in both groups but more
favourably in group B which received Zinc in the form of
suspension. 
The results of the study support the notion that Zinc
reduced the duration and frequency of diarrhoea in
children as seen in both groups. In both groups most of
patients recovered within 3 days after institution of Zinc
treatment.  On comparing both groups, Zinc suspension
was easier to reconstitute and administer in young
infants while the tablets were a bit difficult to utilize
especially in the young ones as it had to be crushed and
mixed with water or milk. Although the role of the Zinc
suspension is statistically significant but has cost
implications. 
The study supports the fact that Zinc is beneficial in the
treatment of acute diarrhoea and can help in reduction
of morbidity and mortality associated with diarrhoeal
illnesses. Moreover, it explores the use of Zinc in
different formulations and delivery mechanism and
supports the suspension form. It appears that the
suspension form is more easy and handy to use
especially in emergency settings. But the cost of syrups
may possibly limit its use as the conventional treatment
of diarrhoea. But before establishing any conclusion
more controlled studies and trials are needed to
establish more evidence in favour of Zinc suspension. 
Specific suggestion concerning the utilization of Zinc
supplementation in any kind of supplementation for the
treatment of acute diarrhoea must look forward to further
population-based studies measuring the role of Zinc
supplementation in diverse formulations for the treat-
ment of acute diarrhoea.
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Table I: Day wise diarrhoea recovery rates.
Group A Group B Total p-value RR (95% CI of RR)
15 33 48
Day 1 19.2% 31.1% 26.1% 0.06 1.17 (0.99-1.39)
45 84 129
Day 2 57.7% 79.2% 70.1% 0.001 2.04 (1.3-3.21)
63 102 164
Day 3 80.8% 96.2% 89.1% 0.001 4.76 (1.63-13.90)
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